DFE Pharma

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40001840

Informations générales

Localisation

Germany

Europe

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

24/10/2024

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2030

Statut

Targets set

Classification

1.5°C

Année cible

2030

Progression vers l'objectif73%
2015 (année de référence)2030
Description complète des objectifs

Energy & Industry: DFE Pharma GmbH & Co. KG commits to reduce absolute scope 1 and 2 GHG emissions 42% by 2030 from a 2021 base year.* DFE Pharma GmbH & Co. KG also commits to reduce absolute scope 3 GHG emissions from purchased goods and services, upstream transportation and distribution, and end-of-life treatment of sold products 25% within the same timeframe. *The target boundary includes land-related emissions and removals from bioenergy feedstocks. FLAG: DFE Pharma GmbH & Co. KG commits to reduce absolute scope 3 FLAG GHG emissions 30.3% by 2030 from a 2021 base year.** DFE Pharma GmbH & Co. KG commits to no deforestation across its primary deforestation-linked commodities, with a target date of December 31, 2025. **The target includes FLAG emissions and removals.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

LEI

529900D9W4X9OOSME741

Source : Science Based Targets initiative | Données publiques